Kenneth R. Pelletier, PhD, MD, is a Clinical Professor of Medicine, Family and d Community Medicine, and Psychiatry at the University of California School of Medicine, San Francisco (UCSF). Dr. Pelletier is also Chairman of the American Health Association and is a Vice President with American Specialty Health. Prior to these positions, Dr. Pelletier served as Clinical Professor of Medicine at Stanford University School of Medicine; was Director of the Stanford Corporate Health Program (SCHP); and was Director of the NIH funded Complementary and Alternative Medicine Program at Stanford (CAMPS). From 1974 until joining the Stanford University School of Medicine in 1990, Dr. Pelletier held a dual appointment as an Associate Clinical Professor in the Department of Medicine and the Department of Psychiatry, University of California School of Medicine in San Francisco (UCSF). At the present time, Dr. Pelletier as a peer reviewer for the Journal of the American Medical Association (JAMA), the Journal of Occupational and Environmental Medicine(JOEM), and Annals of Internal Medicine. He is he author of 15 books including his newest book Change Your Genes – Change Your Life(2024).

Dr. Joan D’souza is a seasoned pharmacovigilance, clinical safety, and regulatory affairs leader with
progressive global experience across the US and Europe in clinical development (Phase I–IV) and
post-marketing safety, supporting biotech and pharmaceutical companies.
She currently serves as a Qualified Person for Pharmacovigilance (QPPV) and Regulatory Affairs
(LCPRA) in Switzerland, Germany, Austria, and Liechtenstein, and as a GVP/GCP auditor, as well as
Deputy local contact person for pharmacovigilance in the UK and Ireland liaising with regulatory
authorities including EMA, FDA, Swissmedic, BfArM, and MHRA. In these roles, she oversees
comprehensive safety surveillance and regulatory compliance across the entire product lifecycle,
from market release decision to regulatory submission.
With a rare combination of qualifications—a medical degree, licensure as a U.S. attorney, a Master’s
degree in Pharmacovigilance and Pharmacoepidemiology, and an ongoing PhD in Drug–Device
Combination Surveillance—Dr. D’souza brings a uniquely multidisciplinary perspective to drug safety
and combination products. She manages end-to-end case processing, medical review, signal
evaluation, aggregate report (DSUR, RMP, PSUR, PBRER, REMS), risk management planning, SOP
development, PSMF oversight, safety report submissions, regulatory authority liaison, and inspection
readiness.
Additionally, her leadership spans oversight of international safety teams, training curriculum
development, and strategic input on safety planning, ensuring clinical oversight and compliance
across product development through all phases of clinical trials and post-marketing activities.
As the founder of JD Pharma Services, a one-stop solution provider for pharmaceutical needs, a
Visiting lecturer for AH Akademie fur Fortbildung Heidelberg, a moderator of the Pharmacovigilance,
Regulatory Affairs, and Drug-Device Combination Working Groups at Zug Pharma Group
(Switzerland), as well as former President of the International Society of Pharmacovigilance Swiss
and Austria Chapter, Dr. D’souza remains a driving force in pharmacovigilance, regulatory oversight,
vendor management, and regulatory submissions. Fluent in English and German, she is dedicated to
advancing patient safety through operational and benefit–risk excellence and regulatory integrity.
Dr. D’souza’s therapeutic experience includes oncology, immunology, cardiology, gastroenterology,
rare diseases, endocrinology, dermatology, and neurology, among others. She remains deeply
committed to advancing patient safety and regulatory excellence in complex global environments.
Dr. Joan D’Souza
CEO
JD Pharma Services
Bridging medical, regulatory, and legal expertise to strengthen global pharmacovigilance compliance.

Associate Professor Dr. Tuan Salwani Tuan Ismail is a Consultant Chemical Pathologist and Head of
the Department of Chemical Pathology at the School of Medical Sciences, Universiti Sains Malaysia
(USM). She also serves as the Director of the Endocrine Laboratory at Hospital Universiti Sains
Malaysia, where she leads clinical diagnostic and research activities in endocrine laboratory medicine.
She obtained her Bachelor of Medicine and Bachelor of Surgery (MBBS) from the University of Malaya
and subsequently completed her Master of Pathology (Chemical Pathology) at Universiti Sains
Malaysia. Her areas of expertise include reproductive endocrinology, diabetes, vitamin D metabolism,
thyroid and parathyroid disorders, and laboratory biomarkers.
Dr. Tuan Salwani has published more than 40 peer-reviewed articles in international journals and has
successfully secured several national and international research grants. Her current research focuses
on Anti-Müllerian Hormone (AMH) as a biomarker of ovarian reserve and reproductive health,
including the establishment of population-specific reference intervals and the evaluation of factors
influencing AMH concentrations. She is also actively involved in translational research on endocrine
biomarkers, metabolomics in diabetes, and the development of novel DNA aptamer-based
technologies for hormone assays.
In addition to her research activities, she contributes to postgraduate education, specialist training,
and scientific peer review for international journals. Through her work, she aims to advance laboratory
diagnostics and translational endocrine research to support evidence-based clinical practice and
improve patient outcomes.

Cristina Iwabe is a distinguished physiotherapist and researcher specializing in pediatric neurology and neuromuscular rehabilitation. She graduated from the University of São Paulo (USP) and earned her specialization, Master's, and Ph.D. in Medical Sciences from Unicamp, where she also completed a postdoctoral fellowship in Neurology and Neuromuscular Disorders. As a collaborating researcher at Unicamp's Neuromuscular Diseases Division, she focuses on rehabilitation strategies for neuromuscular disorders. Dr. Iwabe is the official instructor for the Motor Function Measure (MFM) Scale in Brazil and has extensive expertise in the assessment and rehabilitation of patients with spinal muscular atrophy (SMA) and muscular dystrophies.